SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-18-000100
Filing Date
2018-06-25
Accepted
2018-06-25 16:33:08
Documents
1
Period of Report
2018-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152995877123610.html 4  
1 FORM 4 wf-form4_152995877123610.xml 4 3052
  Complete submission text file 0001600132-18-000100.txt   4523
Mailing Address C/O IKARIA, INC. 6 STATE ROUTE 173 CLINTON NJ 08809
Business Address
Tasse Daniel (Reporting) CIK: 0001502785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 18917359

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations